Chronopharmacology: Appraising the Influence of Biorhythms on the Efficacy and Safety of Antihypertensive Drugs. 2019

Uzma Saleem, and Shafa Iman, and Muhammad Furqan Akhtar, and Ammara Saleem, and Fareeha Anwar, and Bashir Ahmad
Department of Pharmacology, Faculty of Pharmaceutical Sciences, Government College University Faisalabad, Faisalabad, Pakistan.

This review is dedicated to chronopharmacology and chronotherapeutics of hypertension interventions. The aim of chronopharmacology is to determine the most suitable time for administration of a drug to enhance efficacy and safety, prevent tolerance, and minimize the untoward effects of the given therapy. In other words, chronotherapeutics and chronopharmacology optimize drug therapy through matching the disease rhythms to drug availability. Chronobiological principles to optimize the therapeutic effects of antihypertensive drugs attained significance a few decades ago. Circadian rhythm plays a pivotal role in the regulation of blood pressure and expresses as a contender for application of chronotherapeutics. Changes in the normal circadian rhythmic pattern of blood pressure also foretell the risk for developing cardiovascular events. This review highlights studies conducted on the chronopharmacology of different antihypertensive drug classes and prospective areas of chronotherapy to make it comprehensible for application in clinical practice to achieve optimum control of hypertension.

UI MeSH Term Description Entries
D006973 Hypertension Persistently high systemic arterial BLOOD PRESSURE. Based on multiple readings (BLOOD PRESSURE DETERMINATION), hypertension is currently defined as when SYSTOLIC PRESSURE is consistently greater than 140 mm Hg or when DIASTOLIC PRESSURE is consistently 90 mm Hg or more. Blood Pressure, High,Blood Pressures, High,High Blood Pressure,High Blood Pressures
D001794 Blood Pressure PRESSURE of the BLOOD on the ARTERIES and other BLOOD VESSELS. Systolic Pressure,Diastolic Pressure,Pulse Pressure,Pressure, Blood,Pressure, Diastolic,Pressure, Pulse,Pressure, Systolic,Pressures, Systolic
D002940 Circadian Rhythm The regular recurrence, in cycles of about 24 hours, of biological processes or activities, such as sensitivity to drugs or environmental and physiological stimuli. Diurnal Rhythm,Nyctohemeral Rhythm,Twenty-Four Hour Rhythm,Nycthemeral Rhythm,Circadian Rhythms,Diurnal Rhythms,Nycthemeral Rhythms,Nyctohemeral Rhythms,Rhythm, Circadian,Rhythm, Diurnal,Rhythm, Nycthemeral,Rhythm, Nyctohemeral,Rhythm, Twenty-Four Hour,Rhythms, Circadian,Rhythms, Diurnal,Rhythms, Nycthemeral,Rhythms, Nyctohemeral,Rhythms, Twenty-Four Hour,Twenty Four Hour Rhythm,Twenty-Four Hour Rhythms
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000959 Antihypertensive Agents Drugs used in the treatment of acute or chronic vascular HYPERTENSION regardless of pharmacological mechanism. Among the antihypertensive agents are DIURETICS; (especially DIURETICS, THIAZIDE); ADRENERGIC BETA-ANTAGONISTS; ADRENERGIC ALPHA-ANTAGONISTS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CALCIUM CHANNEL BLOCKERS; GANGLIONIC BLOCKERS; and VASODILATOR AGENTS. Anti-Hypertensive,Anti-Hypertensive Agent,Anti-Hypertensive Drug,Antihypertensive,Antihypertensive Agent,Antihypertensive Drug,Anti-Hypertensive Agents,Anti-Hypertensive Drugs,Anti-Hypertensives,Antihypertensive Drugs,Antihypertensives,Agent, Anti-Hypertensive,Agent, Antihypertensive,Agents, Anti-Hypertensive,Agents, Antihypertensive,Anti Hypertensive,Anti Hypertensive Agent,Anti Hypertensive Agents,Anti Hypertensive Drug,Anti Hypertensive Drugs,Anti Hypertensives,Drug, Anti-Hypertensive,Drug, Antihypertensive,Drugs, Anti-Hypertensive,Drugs, Antihypertensive
D019454 Chronotherapy The adaptation of therapeutic approaches such as pharmacological (DRUG CHRONOTHERAPY), surgical, radiological, or physical to the known variations in biological RHYTHMICITY, such as CIRCADIAN RHYTHMS. The treatment is aimed at supporting normal rhythms, or modifying the timing of therapy to achieve maximal efficacy and minimal adverse effect. Chronotherapies

Related Publications

Uzma Saleem, and Shafa Iman, and Muhammad Furqan Akhtar, and Ammara Saleem, and Fareeha Anwar, and Bashir Ahmad
March 1996, Hypertension (Dallas, Tex. : 1979),
Uzma Saleem, and Shafa Iman, and Muhammad Furqan Akhtar, and Ammara Saleem, and Fareeha Anwar, and Bashir Ahmad
March 1996, Journal of hypertension,
Uzma Saleem, and Shafa Iman, and Muhammad Furqan Akhtar, and Ammara Saleem, and Fareeha Anwar, and Bashir Ahmad
January 1999, Acta physiologica et pharmacologica Bulgarica,
Uzma Saleem, and Shafa Iman, and Muhammad Furqan Akhtar, and Ammara Saleem, and Fareeha Anwar, and Bashir Ahmad
January 2005, International braz j urol : official journal of the Brazilian Society of Urology,
Uzma Saleem, and Shafa Iman, and Muhammad Furqan Akhtar, and Ammara Saleem, and Fareeha Anwar, and Bashir Ahmad
March 1976, Lancet (London, England),
Uzma Saleem, and Shafa Iman, and Muhammad Furqan Akhtar, and Ammara Saleem, and Fareeha Anwar, and Bashir Ahmad
January 1993, Drugs,
Uzma Saleem, and Shafa Iman, and Muhammad Furqan Akhtar, and Ammara Saleem, and Fareeha Anwar, and Bashir Ahmad
September 1985, Casopis lekaru ceskych,
Uzma Saleem, and Shafa Iman, and Muhammad Furqan Akhtar, and Ammara Saleem, and Fareeha Anwar, and Bashir Ahmad
January 1989, Vutreshni bolesti,
Uzma Saleem, and Shafa Iman, and Muhammad Furqan Akhtar, and Ammara Saleem, and Fareeha Anwar, and Bashir Ahmad
September 1985, Casopis lekaru ceskych,
Uzma Saleem, and Shafa Iman, and Muhammad Furqan Akhtar, and Ammara Saleem, and Fareeha Anwar, and Bashir Ahmad
January 2000, Eksperimental'naia i klinicheskaia farmakologiia,
Copied contents to your clipboard!